GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network
Interdisciplinary Sciences: Computational Life Sciences · 2024
DOI: 10.1007/s12539-024-00619-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary Sciences: Computational Life Sciences, 2024. Verfasst von Lihong Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Chemistry, Hunan University of Technology, Zhuzhou, 412007, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neural Networks, Computer. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Accumulating studies have demonstrated close relationships between long non-coding RNAs (lncRNAs) and diseases. Identification of new lncRNA-disease associations (LDAs) enables us to better understand disease mechanisms and further provides promising insights into cancer targeted therapy and anti-cancer drug design. Here, we present an LDA prediction framework called GEnDDn based on deep learning. GEnDDn mainly comprises two steps: First, features of both lncRNAs and diseases are extracted by combining similarity computation, non-negative matrix factorization, and graph attention auto-encoder, respectively. And each lncRNA-disease pair (LDP) is depicted as a vector based on concatenation operation on the extracted features. Subsequently, unknown LDPs are classified by aggregating dual-net neural architecture and deep neural network. Using six different evaluation metrics, we found that GEnDDn surpassed four competing LDA identification methods (SDLDA, LDNFSGB, IPCARF, LDASR) on the lncRNADisease and MNDR databases under fivefold cross-validation experiments on lncRNAs, diseases, LDPs, and independent lncRNAs and independent diseases, respectively. Ablation experiments further validated the powerful LDA prediction performance of GEnDDn. Furthermore, we utilized GEnDDn to find underlying lncRNAs for lung cancer and breast cancer. The results elucidated that there may be dense linkages between IFNG-AS1 and lung cancer as well as between HIF1A-AS1 and breast cancer. The results require further biomedical experimental verification. GEnDDn is publicly available at https://github.com/plhhnu/GEnDDn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Chemistry, Hunan University of Technology, Zhuzhou, 412007, China.
- School of Computer Science, Hunan Institute of Technology, Hengyang, 421002, China. chenmin@hnit.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Peng, L., Ren, M., Huang, L., & Chen, M. (2024). GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network. Interdisciplinary Sciences: Computational Life Sciences. https://doi.org/10.1007/s12539-024-00619-w
Vancouver
Peng L, Ren M, Huang L, Chen M. GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network. Interdisciplinary Sciences: Computational Life Sciences. 2024. doi:10.1007/s12539-024-00619-w
BibTeX
@article{Peng2024,
author = {Peng, Lihong and Ren, Mengnan and Huang, Liangliang and Chen, Min},
title = {GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network},
journal = {Interdisciplinary Sciences: Computational Life Sciences},
year = {2024},
doi = {10.1007/s12539-024-00619-w}
}
EUVIMED